Vaniqa (Eflornithine) for PCOS | myPCOSteam

Connect with others who understand.

sign up Log in
Resources
About myPCOSteam
Powered By

Overview
Vaniqa is a prescription drug approved by the Food and Drug Administration (FDA) to reduce unwanted facial hair in women. Vaniqa is also referred to by its drug name, Eflornithine.

Vaniqua is a member of a drug class known as ornithine decarboxylase inhibitors. Vaniqa is believed to work by interfering with hair growth.

How do I take it?
Prescribing information states that Vaniqa is applied topically twice daily.

Vaniqa comes in the form of a cream.

Side effects
The FDA-approved label for Vaniqa lists common side effects including redness, rash, burning, stinging, or razor bumps.

For more details about this treatment, visit:
Vaniqa – Allergan
http://www.vaniqa.com/

Continue with Facebook
Continue with Google
Lock Icon Your privacy is our priority. By continuing, you accept our Terms of use, and our Health Data and Privacy policies.
Already a Member? Log in